Table 2.
Effect of LSEO on stabilization of HRBC membrane in vitro.
| Treatment | Concentration | Absorbance (560 nm) |
% Inhibition of Hemolysis |
IC50 # |
|---|---|---|---|---|
| Control (PBS) | 0.568 | - | - | |
| LSEO (µL/mL) |
6 | 0.370 | 34.917 ± 1.939 D | 6.214 ± 0.776 B |
| 3 | 0.145 | 74.471 ± 0.465 C | ||
| 1.5 | 0.064 | 88.791 ± 0.101 B | ||
| 0.8 | 0.042 | 92.605 ± 0.000 A | ||
| 0.4 | 0.042 | 92.605 ± 0.465 A | ||
| Sodium diclofenac (mg/mL) |
30 | 0.46 | 19.014 ± 12.707 F | 1.198 ± 0.735 A |
| 3 | 0.411 | 27.552 ± 3.354 E | ||
| 0.3 | 0.045 | 92.165 ± 0.419 A | ||
| 0.03 | 0.041 | 92.693 ± 0.227 A | ||
| 0.003 | 0.04 | 92.913 ± 0.221 A |
Each value represents the mean ± SD. LSEO: Lavandula stoechas Essential Oil. IC50: Median Inhibitory Concentration; HRBC: Human Red Blood Cells; PBS: phosphate-buffered saline. # Means within the same column followed by the same letter are not significantly different (p > 0.05) according to ANOVA analysis followed by Tukey’s post hoc multiple comparison tests.